Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025). Rev Alerg Mex. 2025;72(1):52-71. doi:10.29262/fsaxnm03